# Clindesse

NDC: 45802-042
Generic name: clindamycin phosphate
Labeler / Manufacturer: Padagis Israel Pharmaceuticals Ltd
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CREAM
Routes: VAGINAL
Marketing started: 20150703

FDA application: NDA050793

## Active ingredients

- CLINDAMYCIN PHOSPHATE: 100 mg/5g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"45802-042"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=45802-042
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe8bb204-f173-44fe-803b-b08f2ec5aa31